Matches in SemOpenAlex for { <https://semopenalex.org/authorship/W2039203527A5027797923> ?p ?o ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- W2039203527A5027797923 type Authorship @default.
- W2039203527A5027797923 hasAuthor A5027797923 @default.
- W2039203527A5027797923 hasOrganization I168537998 @default.
- W2039203527A5027797923 hasOrganization I17170469 @default.
- W2039203527A5027797923 hasOrganization I201448701 @default.
- W2039203527A5027797923 hasOrganization I4210094549 @default.
- W2039203527A5027797923 hasOrganization I4210096289 @default.
- W2039203527A5027797923 hasOrganization I4210116875 @default.
- W2039203527A5027797923 isCorresponding "false" @default.
- W2039203527A5027797923 position "4" @default.
- W2039203527A5027797923 rawAffiliation "Department of Psychiatry and Behavioral Sciences (CWM, CJ, MC, LCF, AMT, and AJS), University of Washington, Seattle, WA.; Dr. Cherrier has provided consultation to Solvay, Inc. and Merck, Inc.; Dr. Saxon has been on the speaker’s bureau and has received honoraria from Janssen LLC, Alkermes, Cephalon, Forest Pharmaceuticals, and Schering-Plough Canada. He has also provided consultation to Schering-Plough Europe.; Dr. Tapp has been on the speaker’s bureau and has received honoraria from AstraZeneca, Eli Lilly, and Janssen and has received research support from AstraZeneca and Eli Lilly.; From the Mental Health Service (CWM, JPR, CAM, EVY, AK, LCF, AMT, and AJS), Center of Excellence in Substance Abuse Treatment and Education (CAM, LCF, and AJS), VA Puget Sound Health Care System; Received for publication April 23, 2008; The other authors have nothing to disclose and no conflicts of interest.; accepted September 6, 2008." @default.